Many patients use both concurrently: GLP-1 therapy creates the caloric deficit, and Lipo C prevents hepatic steatosis during aggressive restriction
In addition to their effects on appetite, GLPs also appear to impact the brains reward system, which plays a crucial role in craving and addictive behaviors
I truly appreciate the intention to explore performance and recovery science more deeply
16 On the other hand, the investigational use of GIPR agonists (GIPRAs) has not yielded similar advantages, partly because of a lack of understanding of GIP dose-response actions
Nowadays, FOXO4-DRI studies are focused on the following aspects: osteoarthritis (senescent chondrocyte clearance), metabolic dysfunction (insulin resistance and obesity-associated senescence), neurodegeneration (eliminating senescent brain cells), and fibrotic diseases (idiopathic pulmonary and liver fibrosis)
It reduces contamination risk but does not prevent chemical degradation of the peptide